StockMacro
Menu

Ascendis Pharma A/S Ordinary Share

$252.73 +5.5% in 6 monthsMarket cap $16.6B

ASND on XNAS, job postings

Measures activity, not value. Not investment advice.

Institutional holders rose 13% to 346 while the stock is up 21% in a year.

Written by AI from the data on this page, 21 Nov 2026. Not investment advice.

Profile and fundamentals

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Employees
1,189
Website
ascendispharma.com
Listed
Nasdaq, US

No income statement in this company's recent SEC filings in our data (it may report under IFRS, in another currency, or not file with the SEC).

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

-$6.2M

bought $0, sold $6.2M

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

+13%

346 13F filers vs 307

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

over 100%

68.3M shares held by 13F filers (30 Sep 2026) of 62.0M outstanding (31 Dec 2025); above 100%: the share count is probably stale

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

4.8%

3.0M shares sold short (30 Oct 2026) of 62.0M outstanding (31 Dec 2025)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

5.0

3.0M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

-4.3%

3.1M shares sold short in the report before, 3.0M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

53%

53% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 52%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

–

No data for this company

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

$30.1

the 12 months before: $210K

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$760K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

24

24 articles in the last 7 days; its usual week has 2 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

12×

24 articles in the last 7 days; its usual week has 2.

Price $252.73 on 20 Nov 2026, +21% over 12 months (12-month range $196.63 to $277.18)

  • Sharp change
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $10.0M in the last 12 months (the 12 months before: $0).
H-1B/E-3 applications certified. H-1B/E-3 applications certified: 2 published in the last 12 months (none in the 12 months before).
Institutional holders (13F filers). 346 13F filers reported holding it in the latest 13F quarter, +29% on a year earlier.
Federal obligations. Federal obligations: $30.1 published in the last 12 months, -100% on the 12 months before.
Lobbying spend. Lobbying spend: $760K published in the last 12 months, +31% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: revenue per quarter, capital spending per quarter, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
22 Oct 2024Lobbying filinglobbying engagement terminated (in-house)
14 May 2024Sharp changeLobbying spend jump: lobbying spend jump, 280K vs usual 130K (2024-03-31); 1.3x the same period a year earlier
15 Nov 2022Sharp changeMany funds opening a new position: many funds opening a new position, 35 vs usual 20.50 (2022-09-30); 1.5x the same period a year earlier
2 Aug 2022Sharp changeShort interest spike: short interest spike, 6.9M vs usual 2.8M (2022-07-15); 2.6x the same period a year earlier
19 Jul 2022Sharp changeShort interest spike: short interest spike, 6.5M vs usual 2.8M (2022-06-30); 2.4x the same period a year earlier
28 Jun 2022Sharp changeShort interest spike: short interest spike, 5.9M vs usual 2.8M (2022-06-15); 2.1x the same period a year earlier
14 Jun 2022Sharp changeShort interest spike: short interest spike, 6.4M vs usual 2.8M (2022-05-31); 2.1x the same period a year earlier
31 May 2022Sharp changeShort interest spike: short interest spike, 6.7M vs usual 2.8M (2022-05-13); 2.3x the same period a year earlier
17 May 2022Sharp changeShort interest spike: short interest spike, 5.8M vs usual 2.8M (2022-04-29); 1.9x the same period a year earlier
3 May 2022Sharp changeShort interest spike: short interest spike, 6.3M vs usual 2.8M (2022-04-14); 2.1x the same period a year earlier
12 Apr 2022Sharp changeShort interest spike: short interest spike, 6.3M vs usual 2.8M (2022-03-31); 2.2x the same period a year earlier
29 Mar 2022Sharp changeShort interest spike: short interest spike, 4.6M vs usual 2.7M (2022-03-15); 1.6x the same period a year earlier
Insider net buying (open market)
Month from 1 May 2026: -$4.5M published
Month from 1 Jun 2026: $189K published
Month from 1 Aug 2026: $493K published
Month from 1 Sep 2026: -$873K published
Month from 1 Nov 2026: -$5.3M published
H-1B/E-3 applications certified
Quarter from 1 Jan 2022: 1 published
Quarter from 1 Jul 2022: 2 published
Quarter from 1 Oct 2022: 1 published
Quarter from 1 Apr 2023: 3 published
Quarter from 1 Jul 2023: 2 published
Quarter from 1 Oct 2023: 1 published
Quarter from 1 Oct 2024: 1 published
Quarter from 1 Jan 2026: 1 published
Quarter from 1 Oct 2026: 1 published
Institutional holders (13F filers)
31 Dec 2021 report: 157; public on 14 Feb 2022
31 Mar 2022 report: 169; public on 16 May 2022
30 Jun 2022 report: 156; public on 15 Aug 2022
30 Sep 2022 report: 170; public on 14 Nov 2022
31 Dec 2022 report: 178; public on 14 Feb 2023
31 Mar 2023 report: 157; public on 15 May 2023
30 Jun 2023 report: 149; public on 14 Aug 2023
30 Sep 2023 report: 148; public on 14 Nov 2023
31 Dec 2023 report: 174; public on 14 Feb 2024
31 Mar 2024 report: 184; public on 15 May 2024
30 Jun 2024 report: 195; public on 14 Aug 2024
30 Sep 2024 report: 209; public on 14 Nov 2024
31 Dec 2024 report: 208; public on 14 Feb 2025
31 Mar 2025 report: 235; public on 15 May 2025
30 Jun 2025 report: 234; public on 14 Aug 2025
30 Sep 2025 report: 268; public on 14 Nov 2025
31 Dec 2025 report: 296; public on 17 Feb 2026
31 Mar 2026 report: 266; public on 15 May 2026
30 Jun 2026 report: 307; public on 14 Aug 2026
30 Sep 2026 report: 346; public on 16 Nov 2026
Federal obligations
Month from 1 Jul 2025: $210K published
Month from 1 Feb 2026: $30.1 published
Lobbying spend
Quarter from 1 Jan 2022: $130K published
Quarter from 1 Apr 2022: $180K published
Quarter from 1 Jul 2022: $130K published
Quarter from 1 Oct 2022: $120K published
Quarter from 1 Jan 2023: $140K published
Quarter from 1 Apr 2023: $210K published
Quarter from 1 Jul 2023: $120K published
Quarter from 1 Oct 2023: $130K published
Quarter from 1 Jan 2024: $130K published
Quarter from 1 Apr 2024: $280K published
Quarter from 1 Jul 2024: $100K published
Quarter from 1 Oct 2024: $60K published
Quarter from 1 Jan 2025: $100K published
Quarter from 1 Apr 2025: $150K published
Quarter from 1 Jul 2025: $160K published
Quarter from 1 Oct 2025: $170K published
Quarter from 1 Jan 2026: $170K published
Quarter from 1 Apr 2026: $250K published
Quarter from 1 Jul 2026: $170K published
Quarter from 1 Oct 2026: $170K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $5.3M (18 Nov 2026), higher than 100% of its own history.
  • Insider net buying (open market): Insiders sold a net $10.0M in the last 12 months (the 12 months before: $0).
  • H-1B/E-3 applications certified: H-1B/E-3 applications certified: 2 published in the last 12 months (none in the 12 months before).
  • Institutional holders (13F filers): 346 13F filers reported holding it in the latest 13F quarter, +29% on a year earlier.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 9 insider trades

Last 90 days: 3 sales, $6.2M; no purchases. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
18 Nov 2026Pedersen Anni Lotte Kirstine SonderbjergEVP & Chief Admin OfficerSellafter exercising options20,000$263.89$5.3MForm 4
9 Sep 2026Mads BodenhoffSVP & PAOSellafter exercising options3,000$270.19$811KForm 4
3 Sep 2026Lars HoltugDirectorSell236$264.13$62KForm 4
18 Aug 2026Jean Jacques BienaimeDirectorBuy2,000$246.33$493KForm 4
2 Jun 2026Scott Thomas SmithEVP & Chief Financial OfficerBuy100$219.00$22KForm 4
1 Jun 2026Jean Jacques BienaimeDirectorBuy500$223.12$112KForm 4
1 Jun 2026Scott Thomas SmithEVP & Chief Financial OfficerBuy250$223.32$56KForm 4
27 May 2026Jean Jacques BienaimeDirectorBuy400$237.81$95KForm 4

346 institutions reported shares at the end of Q3 2026, 100% of the shares outstanding; 74 opened a position, 41 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Ra Capital Management, L.P.10.3M16.6%$2.3BNo change
T. Rowe Price Investment Management, Inc.8.2M13.2%+1.4M+21%
Westfield Capital Management Co LP5.1M8.27%$1.2B+327K+6.8%
Avoro Capital Advisors LLC5.0M8.15%$1.2B-61K-1.2%
Janus Henderson Group Ltd.3.6M5.87%$828.5M
FMR LLC (Fidelity)3.4M5.56%$785.0M-100K-2.8%
Wellington Management Group LLP3.1M4.95%$699.5M+1.5M+98%
BlackRock, Inc.2.3M3.69%$520.4M+72K+3.3%
Artisan Partners Limited Partnership2.1M3.36%$474.6M-551K-21%
Massachusetts Financial Services Co1.9M3.06%$431.9M+21K+1.1%

Reported lobbying spend: $170K in Q3 2026, $170K in Q2 2026. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
30 Sep 2024EndedAscendis Pharma, LLCits own lobbyistsNot statedFiling
30 Nov 2020NewAscendis Pharma, LLCits own lobbyistsFood and Drug Administration, Orphan DrugsHealth issues, PharmacyFiling
27 May 2020NewRubicon Advisors, LLCfor Ascendis Pharma, Inc.Food and Drug Administration,Orphan DrugsPharmacyFiling

The 5 newest of 145 articles that name the company.

Timeline

Timeline

Changes and notable records, by the date each became public

  1. 19 Aug 2026Insiders record

    BIENAIME JEAN JACQUES (director) bought 2,000 shares of ASND ($492,654) (dated 18 Aug 2026)

  2. 3 Jun 2026Insiders record

    SMITH SCOTT THOMAS (EVP & Chief Financial Officer) bought 100 shares of ASND ($21,900) (dated 2 Jun 2026)

  3. 2 Jun 2026Insiders record

    BIENAIME JEAN JACQUES (director) bought 500 shares of ASND ($111,562) (dated 1 Jun 2026)

  4. 2 Jun 2026Insiders record

    SMITH SCOTT THOMAS (EVP & Chief Financial Officer) bought 250 shares of ASND ($55,830) (dated 1 Jun 2026)

  5. 28 May 2026Insiders record

    BIENAIME JEAN JACQUES (director) bought 400 shares of ASND ($95,122) (dated 27 May 2026)

  6. 22 Oct 2024Lobbying record

    ASCENDIS PHARMA, LLC: lobbying engagement terminated (in-house) (dated 30 Sep 2024)

  7. 8 May 2024Lobbying change

    reported $280K of lobbying spend for the quarter ended 31 Mar 2024, 1.3× the same quarter last year.

    Same quarter last year: $210K; its normal quarter is $130K.

    See the evidence
    This period
    $280K (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $130K
    Typical spread (median absolute deviation)
    $10K
    How far from its usual level
    +7.5
    Same quarter last year
    $210K
    History used
    1,370 days
    2022-03-31: $180K2022-06-30: $130K2022-09-30: $120K2022-12-31: $140K2023-03-31: $210K2023-06-30: $120K2023-09-30: $130K2023-12-31: $130K2024-03-31: $280K
    the quarter ended 31 Mar 20248 earlier quartersnormal: $130K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least $100K.

    Check it at the source: Senate/House lobbying disclosures (LDA).

  8. 14 Nov 2022Institutional holdings change

    saw 35 13F filers open a new position in the quarter ended 30 Sep 2022, 1.5× the same quarter last year.

    Same quarter last year: 23; its normal quarter is 20.5.

    See the evidence
    This period
    35 (the quarter ended 30 Sep 2022)
    Normal quarter (median of 8 earlier)
    20.5
    Typical spread (median absolute deviation)
    2
    How far from its usual level
    +4.8
    Same quarter last year
    23
    History used
    2,740 days
    2020-09-30: 182020-12-31: 222021-03-31: 192021-06-30: 192021-09-30: 232021-12-31: 222022-03-31: 252022-06-30: 182022-09-30: 35
    the quarter ended 30 Sep 20228 earlier quartersnormal: 20.5

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.

    Check it at the source: SEC Form 13F data sets.

  9. 27 Jul 2022Short interest and volume change

    had 6.9M shares sold short in the 15 Jul 2022 report, 2.6× the same report last year.

    Same report last year: 2.7M; its normal report is 2.8M.

    See the evidence
    This period
    6.9M (the 15 Jul 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    454K
    How far from its usual level
    +6.0
    Same report last year
    2.7M
    History used
    1,659 days
    2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M2022-04-29: 5.8M2022-05-13: 6.7M2022-05-31: 6.4M2022-06-15: 5.9M2022-06-30: 6.5M2022-07-15: 6.9M
    the 15 Jul 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  10. 13 Jul 2022Short interest and volume change

    had 6.5M shares sold short in the 30 Jun 2022 report, 2.4× the same report last year.

    Same report last year: 2.7M; its normal report is 2.8M.

    See the evidence
    This period
    6.5M (the 30 Jun 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    391K
    How far from its usual level
    +6.4
    Same report last year
    2.7M
    History used
    1,644 days
    2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M2022-04-29: 5.8M2022-05-13: 6.7M2022-05-31: 6.4M2022-06-15: 5.9M2022-06-30: 6.5M
    the 30 Jun 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  11. 28 Jun 2022Short interest and volume change

    had 5.9M shares sold short in the 15 Jun 2022 report, 2.1× the same report last year.

    Same report last year: 2.8M; its normal report is 2.8M.

    See the evidence
    This period
    5.9M (the 15 Jun 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    373K
    How far from its usual level
    +5.7
    Same report last year
    2.8M
    History used
    1,629 days
    2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M2022-04-29: 5.8M2022-05-13: 6.7M2022-05-31: 6.4M2022-06-15: 5.9M
    the 15 Jun 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  12. 10 Jun 2022Short interest and volume change

    had 6.4M shares sold short in the 31 May 2022 report, 2.1× the same report last year.

    Same report last year: 3.0M; its normal report is 2.8M.

    See the evidence
    This period
    6.4M (the 31 May 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    349K
    How far from its usual level
    +6.9
    Same report last year
    3.0M
    History used
    1,614 days
    2021-05-14: 3.0M2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M2022-04-29: 5.8M2022-05-13: 6.7M2022-05-31: 6.4M
    the 31 May 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  13. 25 May 2022Short interest and volume change

    had 6.7M shares sold short in the 13 May 2022 report, 2.3× the same report last year.

    Same report last year: 3.0M; its normal report is 2.8M.

    See the evidence
    This period
    6.7M (the 13 May 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    287K
    How far from its usual level
    +9.3
    Same report last year
    3.0M
    History used
    1,596 days
    2021-04-30: 3.0M2021-05-14: 3.0M2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M2022-04-29: 5.8M2022-05-13: 6.7M
    the 13 May 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  14. 11 May 2022Short interest and volume change

    had 5.8M shares sold short in the 29 Apr 2022 report, 1.9× the same report last year.

    Same report last year: 3.0M; its normal report is 2.8M.

    See the evidence
    This period
    5.8M (the 29 Apr 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    221K
    How far from its usual level
    +9.0
    Same report last year
    3.0M
    History used
    1,582 days
    2021-04-15: 3.0M2021-04-30: 3.0M2021-05-14: 3.0M2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M2022-04-29: 5.8M
    the 29 Apr 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  15. 27 Apr 2022Short interest and volume change

    had 6.3M shares sold short in the 14 Apr 2022 report, 2.1× the same report last year.

    Same report last year: 3.0M; its normal report is 2.8M.

    See the evidence
    This period
    6.3M (the 14 Apr 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    203K
    How far from its usual level
    +11.6
    Same report last year
    3.0M
    History used
    1,567 days
    2021-03-31: 2.9M2021-04-15: 3.0M2021-04-30: 3.0M2021-05-14: 3.0M2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M2022-04-14: 6.3M
    the 14 Apr 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  16. 12 Apr 2022Short interest and volume change

    had 6.3M shares sold short in the 31 Mar 2022 report, 2.2× the same report last year.

    Same report last year: 2.9M; its normal report is 2.8M.

    See the evidence
    This period
    6.3M (the 31 Mar 2022 report)
    Normal report (median of 24 earlier)
    2.8M
    Typical spread (median absolute deviation)
    199K
    How far from its usual level
    +11.9
    Same report last year
    2.9M
    History used
    1,553 days
    2021-03-15: 2.9M2021-03-31: 2.9M2021-04-15: 3.0M2021-04-30: 3.0M2021-05-14: 3.0M2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M2022-03-31: 6.3M
    the 31 Mar 2022 report24 earlier reportsnormal: 2.8M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  17. 25 Mar 2022Short interest and volume change

    had 4.6M shares sold short in the 15 Mar 2022 report, 1.6× the same report last year.

    Same report last year: 2.9M; its normal report is 2.7M.

    See the evidence
    This period
    4.6M (the 15 Mar 2022 report)
    Normal report (median of 24 earlier)
    2.7M
    Typical spread (median absolute deviation)
    251K
    How far from its usual level
    +4.9
    Same report last year
    2.9M
    History used
    1,537 days
    2021-02-26: 2.5M2021-03-15: 2.9M2021-03-31: 2.9M2021-04-15: 3.0M2021-04-30: 3.0M2021-05-14: 3.0M2021-05-28: 3.0M2021-06-15: 2.8M2021-06-30: 2.7M2021-07-15: 2.7M2021-07-30: 2.7M2021-08-13: 2.8M2021-08-31: 2.7M2021-09-15: 2.5M2021-09-30: 2.4M2021-10-15: 2.4M2021-10-29: 2.4M2021-11-15: 2.4M2021-11-30: 2.6M2021-12-15: 2.6M2022-01-14: 2.8M2022-01-31: 3.6M2022-02-15: 3.5M2022-02-28: 3.8M2022-03-15: 4.6M
    the 15 Mar 2022 report24 earlier reportsnormal: 2.7M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  18. 26 May 2021Short interest and volume change

    had 3.0M shares sold short in the 14 May 2021 report, 1.5× the same report last year.

    Same report last year: 2.0M; its normal report is 2.1M.

    See the evidence
    This period
    3.0M (the 14 May 2021 report)
    Normal report (median of 24 earlier)
    2.1M
    Typical spread (median absolute deviation)
    142K
    How far from its usual level
    +4.5
    Same report last year
    2.0M
    History used
    1,232 days
    2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.7M2020-07-31: 1.8M2020-08-14: 1.9M2020-08-31: 2.0M2020-09-15: 2.1M2020-09-30: 1.9M2020-10-15: 1.9M2020-10-30: 1.9M2020-11-13: 1.9M2020-11-30: 2.2M2020-12-15: 2.3M2020-12-31: 2.2M2021-01-15: 2.2M2021-01-29: 2.1M2021-02-12: 2.2M2021-02-26: 2.5M2021-03-15: 2.9M2021-03-31: 2.9M2021-04-15: 3.0M2021-04-30: 3.0M2021-05-14: 3.0M
    the 14 May 2021 report24 earlier reportsnormal: 2.1M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  19. 12 May 2021Short interest and volume change

    had 3.0M shares sold short in the 30 Apr 2021 report, 1.6× the same report last year.

    Same report last year: 1.9M; its normal report is 2.0M.

    See the evidence
    This period
    3.0M (the 30 Apr 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    124K
    How far from its usual level
    +4.8
    Same report last year
    1.9M
    History used
    1,218 days
    2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.7M2020-07-31: 1.8M2020-08-14: 1.9M2020-08-31: 2.0M2020-09-15: 2.1M2020-09-30: 1.9M2020-10-15: 1.9M2020-10-30: 1.9M2020-11-13: 1.9M2020-11-30: 2.2M2020-12-15: 2.3M2020-12-31: 2.2M2021-01-15: 2.2M2021-01-29: 2.1M2021-02-12: 2.2M2021-02-26: 2.5M2021-03-15: 2.9M2021-03-31: 2.9M2021-04-15: 3.0M2021-04-30: 3.0M
    the 30 Apr 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  20. 27 Apr 2021Short interest and volume change

    had 3.0M shares sold short in the 15 Apr 2021 report, 1.5× the same report last year.

    Same report last year: 2.1M; its normal report is 2.0M.

    See the evidence
    This period
    3.0M (the 15 Apr 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    122K
    How far from its usual level
    +4.8
    Same report last year
    2.1M
    History used
    1,203 days
    2020-04-15: 2.1M2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.7M2020-07-31: 1.8M2020-08-14: 1.9M2020-08-31: 2.0M2020-09-15: 2.1M2020-09-30: 1.9M2020-10-15: 1.9M2020-10-30: 1.9M2020-11-13: 1.9M2020-11-30: 2.2M2020-12-15: 2.3M2020-12-31: 2.2M2021-01-15: 2.2M2021-01-29: 2.1M2021-02-12: 2.2M2021-02-26: 2.5M2021-03-15: 2.9M2021-03-31: 2.9M2021-04-15: 3.0M
    the 15 Apr 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  21. 13 Apr 2021Short interest and volume change

    had 2.9M shares sold short in the 31 Mar 2021 report, 1.5× the same report last year.

    Same report last year: 2.0M; its normal report is 2.0M.

    See the evidence
    This period
    2.9M (the 31 Mar 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    108K
    How far from its usual level
    +4.5
    Same report last year
    2.0M
    History used
    1,188 days
    2020-03-31: 2.0M2020-04-15: 2.1M2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.7M2020-07-31: 1.8M2020-08-14: 1.9M2020-08-31: 2.0M2020-09-15: 2.1M2020-09-30: 1.9M2020-10-15: 1.9M2020-10-30: 1.9M2020-11-13: 1.9M2020-11-30: 2.2M2020-12-15: 2.3M2020-12-31: 2.2M2021-01-15: 2.2M2021-01-29: 2.1M2021-02-12: 2.2M2021-02-26: 2.5M2021-03-15: 2.9M2021-03-31: 2.9M
    the 31 Mar 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  22. 25 Mar 2021Short interest and volume change

    had 2.9M shares sold short in the 15 Mar 2021 report, 1.4× the same report last year.

    Same report last year: 2.1M; its normal report is 2.0M.

    See the evidence
    This period
    2.9M (the 15 Mar 2021 report)
    Normal report (median of 24 earlier)
    2.0M
    Typical spread (median absolute deviation)
    105K
    How far from its usual level
    +4.2
    Same report last year
    2.1M
    History used
    1,172 days
    2020-03-13: 2.1M2020-03-31: 2.0M2020-04-15: 2.1M2020-04-30: 1.9M2020-05-15: 2.0M2020-05-29: 2.0M2020-06-15: 2.0M2020-06-30: 1.9M2020-07-15: 1.7M2020-07-31: 1.8M2020-08-14: 1.9M2020-08-31: 2.0M2020-09-15: 2.1M2020-09-30: 1.9M2020-10-15: 1.9M2020-10-30: 1.9M2020-11-13: 1.9M2020-11-30: 2.2M2020-12-15: 2.3M2020-12-31: 2.2M2021-01-15: 2.2M2021-01-29: 2.1M2021-02-12: 2.2M2021-02-26: 2.5M2021-03-15: 2.9M
    the 15 Mar 2021 report24 earlier reportsnormal: 2.0M

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  23. 14 Jan 2021Lobbying record

    ASCENDIS PHARMA, LLC: new lobbying registration (in-house) (dated 30 Nov 2020)

  24. 24 Jun 2020Lobbying change

    registered for federal lobbying for the first time in our data (Rubicon Advisors, Llc).

    See the evidence (1 source record)
    Source coverage starts
    5 Oct 2010
    Earlier events of other kinds
    0

    "First" means first in our data: it fires only when the source's history began at least 365 days earlier.

  25. 24 Jun 2020Lobbying record

    ASCENDIS PHARMA, INC.: new lobbying registration (RUBICON ADVISORS, LLC) (dated 27 May 2020)

  26. 26 Apr 2019Short interest and volume change

    had 1.6M shares sold short in the 15 Apr 2019 report, 7.1× the same report last year.

    Same report last year: 226K; its normal report is 385K.

    See the evidence
    This period
    1.6M (the 15 Apr 2019 report)
    Normal report (median of 24 earlier)
    385K
    Typical spread (median absolute deviation)
    161K
    How far from its usual level
    +5.1
    Same report last year
    226K
    History used
    472 days
    2018-04-13: 226K2018-04-30: 237K2018-05-15: 234K2018-05-31: 221K2018-06-15: 250K2018-06-29: 270K2018-07-13: 310K2018-07-31: 300K2018-08-15: 290K2018-08-31: 343K2018-09-14: 377K2018-09-28: 393K2018-10-15: 364K2018-10-31: 670K2018-11-15: 632K2018-11-30: 821K2018-12-14: 699K2018-12-31: 669K2019-01-15: 768K2019-01-31: 690K2019-02-15: 879K2019-02-28: 995K2019-03-15: 1.4M2019-03-29: 1.4M2019-04-15: 1.6M
    the 15 Apr 2019 report24 earlier reportsnormal: 385K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  27. 10 Apr 2019Short interest and volume change

    had 1.4M shares sold short in the 29 Mar 2019 report, 2.6× the same report last year.

    Same report last year: 550K; its normal report is 385K.

    See the evidence
    This period
    1.4M (the 29 Mar 2019 report)
    Normal report (median of 24 earlier)
    385K
    Typical spread (median absolute deviation)
    161K
    How far from its usual level
    +4.3
    Same report last year
    550K
    History used
    455 days
    2018-03-29: 550K2018-04-13: 226K2018-04-30: 237K2018-05-15: 234K2018-05-31: 221K2018-06-15: 250K2018-06-29: 270K2018-07-13: 310K2018-07-31: 300K2018-08-15: 290K2018-08-31: 343K2018-09-14: 377K2018-09-28: 393K2018-10-15: 364K2018-10-31: 670K2018-11-15: 632K2018-11-30: 821K2018-12-14: 699K2018-12-31: 669K2019-01-15: 768K2019-01-31: 690K2019-02-15: 879K2019-02-28: 995K2019-03-15: 1.4M2019-03-29: 1.4M
    the 29 Mar 2019 report24 earlier reportsnormal: 385K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

  28. 27 Mar 2019Short interest and volume change

    had 1.4M shares sold short in the 15 Mar 2019 report, 2.1× the same report last year.

    Same report last year: 628K; its normal report is 385K.

    See the evidence
    This period
    1.4M (the 15 Mar 2019 report)
    Normal report (median of 24 earlier)
    385K
    Typical spread (median absolute deviation)
    161K
    How far from its usual level
    +4.0
    Same report last year
    628K
    History used
    441 days
    2018-03-15: 628K2018-03-29: 550K2018-04-13: 226K2018-04-30: 237K2018-05-15: 234K2018-05-31: 221K2018-06-15: 250K2018-06-29: 270K2018-07-13: 310K2018-07-31: 300K2018-08-15: 290K2018-08-31: 343K2018-09-14: 377K2018-09-28: 393K2018-10-15: 364K2018-10-31: 670K2018-11-15: 632K2018-11-30: 821K2018-12-14: 699K2018-12-31: 669K2019-01-15: 768K2019-01-31: 690K2019-02-15: 879K2019-02-28: 995K2019-03-15: 1.4M
    the 15 Mar 2019 report24 earlier reportsnormal: 385K

    Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.

    Check it at the source: FINRA short interest data.

Not listed: 15 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001612042
Ticker
ASND
Domain
ascendispharma.com
Employer name
Ascendis Pharma Inc. (1 unverified)
Lobbying client
ascendis pharma
Name
Ascendis Pharma A/S Ordinary Share
Uei
KV6MU52GJMF5, T2AMZHL9TMM4, UKN2MTNJ9WM5
Wikidata
Q104479983
  • DOL H-1B labor condition applications and PERM certifications86 data points24 Aug 2020 to 3 Aug 2026
  • Federal lobbying disclosures (LDA)3 records, 78 data points27 May 2020 to 30 Sep 2026
  • SEC Form 13F institutional holdings423 data points31 Mar 2015 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)11 records15 Apr 2016 to 11 Feb 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)9 data points31 Dec 2017 to 31 Dec 2025
  • SEC Form 4 insider transactions9 records, 32 data points12 May 2026 to 18 Nov 2026
  • FINRA short interest (twice monthly)636 data points29 Dec 2017 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)4178 data points1 Aug 2018 to 20 Nov 2026
  • USASpending.gov federal awards6 data points15 Jul 2025 to 4 Feb 2026